Meclizine HCL 12.5 mg
NDC 17714-117, Meclizine HCL 12.5 mg, tablet, from Advance Pharmaceutical Inc..
- Product NDC
- 17714-117
- Status
- Listed
- Labeler
- Advance Pharmaceutical Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH FINAL
- Application
- part336
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17714-117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MECLIZINE HYDROCHLORIDE12.5 mg/1
Pharmacologic classes
Antiemetic [EPC]; Emesis Suppression [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17714-117-01 | 17714011701 | 100 TABLET in 1 BOTTLE (17714-117-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 17714-117 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17714-117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17714-117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.